Press Releases April 13, 2026 08:00 PM

Upwork to Report First Quarter Financial Results on May 7, 2026

Upwork schedules Q1 2026 financial results announcement and conference call for May 7, 2026

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
UPWK

Upwork Inc., a Nasdaq-listed company specializing in AI-powered freelance and contingent workforce solutions, will release its first quarter 2026 financial results after market close on May 7, 2026, followed by a conference call. The company connects global businesses with skilled talent across multiple sectors including technology, sales, marketing, and finance through its Upwork Marketplace and Lifted platform.

Upwork to Report First Quarter Financial Results on May 7, 2026
UPWK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Upwork will report Q1 2026 financial results on May 7, 2026, with a live webcast and conference call accessible to investors.
  • The company offers AI-enhanced talent sourcing across diverse job types such as freelance and payrolled roles through its Upwork Marketplace and Lifted solutions.
  • Upwork serves a wide spectrum of clients from Fortune 100 enterprises to entrepreneurs, facilitating over $30 billion in transactions to date.

PALO ALTO, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that it will report its financial results for the first quarter of 2026 on Thursday, May 7, 2026 after market close. The company will host a Q&A conference call to discuss these results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day.

A live webcast of the call will be available on the Upwork Investor Relations website at investors.upwork.com.

An audio replay of the conference call will be available for one week following the call and will be archived via webcast on the Upwork Investor Relations website at investors.upwork.com for approximately one year.

About Upwork
Upwork Inc.’s (Nasdaq: UPWK) family of companies connects businesses with global, AI-enabled talent across every on-demand work type including freelance, agency, fractional, and payrolled. This portfolio includes the Upwork Marketplace, which connects businesses with on-demand access to highly skilled talent across the globe, and Lifted, which provides a purpose-built solution for enterprise organizations to source, contract, manage, and pay talent across the full spectrum of contingent work. From Fortune 100 enterprises to entrepreneurs, businesses rely on Upwork Inc. to find and hire expert talent, leverage AI-powered work solutions, and drive business transformation. With access to professionals spanning more than 10,000 skills across AI & machine learning, software development, sales & marketing, customer support, finance & accounting, and more, the Upwork family of companies enables businesses of all sizes to scale, innovate, and transform their workforces for the age of AI and beyond.

Since its founding, Upwork Inc. has facilitated more than $30 billion in total transactions and services as it fulfills its purpose to create opportunity in every era of work. Learn more about the Upwork Marketplace at upwork.com and follow on LinkedIn, Facebook, Instagram, TikTok, and X; and learn more about Lifted at go-lifted.com and follow on LinkedIn.

Investor Relations Contact:
Gary J. Fuges, CFA
Vice President of Investor Relations
[email protected]

Media Contact:
Janine Kamwene
Vice President of Communications
[email protected]


Risks

  • Uncertainty around the upcoming quarterly financial results might affect investor sentiment and stock price movement.
  • Market competition in the freelance and contingent labor marketplaces poses ongoing challenges to growth and profitability.
  • Economic shifts impacting global hiring trends could influence Upwork's business volume and revenue trajectory.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026